Data from the Health Resources and Services Administration reveals discounted drugs through the program reached $43.9 billion in 2021, and in 2022, purchases were $53.7 billion. The value of those drugs is nearly twice the amount paid, or $106 billion.
Disproportionate share hospitals spent $41.8 billion on 340B discounted medications, and children’s hospitals, critical access hospitals, cancer centers and other grantees accounted for about 20 percent of the total share of purchases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
